Anti-21-Hydroxylase Antibody
The anti-21-hydroxylase antibody test measures the presence of antibodies against the 21-hydroxylase enzyme, which is crucial for cortisol synthesis.
This test detects antibodies against 21-hydroxylase, aiding in the diagnosis of autoimmune adrenal disorders.
Key facts at a glance
- Units
- U/mL
- Clinical utility
- diagnostic
- Result kind
- qualitative
- FDA-cleared
- Roche 21-OH Ab, Iowa 21-Hydroxylase Ab
The anti-21-hydroxylase antibody test is primarily used to diagnose autoimmune conditions affecting the adrenal glands, such as Addison's disease. In these conditions, the body produces antibodies that attack the 21-hydroxylase enzyme, leading to decreased cortisol production.
Cortisol is a vital hormone that helps the body respond to stress, regulate blood sugar, and reduce inflammation. A deficiency in cortisol can cause a range of symptoms, including fatigue, weight loss, and low blood pressure.
The normal reference range for anti-21-hydroxylase antibodies is 0–1 U/mL. Levels above this range may indicate the presence of an autoimmune adrenal disorder.
Frequently asked questions
What does a positive anti-21-hydroxylase antibody test mean?
Can this test be used to monitor disease progression?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy